Ballicules.com

Mecamylamine

INVERSINE

What it isGanglionic nicotinic antagonist; historical antihypertensive, studied in smoking cessation.

Why this oneIt is one of the few centrally acting nicotinic antagonists, which is why it was revisited for addiction.

What limits itBlocking both autonomic limbs causes constipation, retention and orthostasis. Largely obsolete.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Hypertension (moderately severe to severe essential; uncomplicated malignant)Adult2.5 mg BID~25 mg/day in ~3 divided doses

Titration Increase by 2.5 mg increments at intervals of not less than 2 days until desired response.

Renal Contraindicated in uremia; give with great discretion, if at all, when renal insufficiency is manifested by rising/elevated BUN.

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Pregnancy Category C; use only if clearly needed.

Lactation Undefined

NO BOXED WARNINGS

Principal riskBlocking both autonomic limbs causes constipation, retention and orthostasis

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Mecamylamine ballicule

Mecamylamine ballicule: receptor binding, kinetics and half-life diagram

Open Mecamylamine in the interactive console ↗